Literature DB >> 21325781

A negative correlation between expression profiles of runt-related transcription factor-2 and cystine/glutamate antiporter xCT subunit in ovariectomized mouse bone.

Kyosuke Uno1, Takeshi Takarada, Yukari Nakamura, Hiroyuki Fujita, Eiichi Hinoi, Yukio Yoneda.   

Abstract

We have previously demonstrated that glutamate (Glu) suppresses cellular proliferation toward self-renewal through a mechanism associated with the depletion of intracellular GSH after promoting the retrograde operation of the bidirectional cystine/Glu antiporter in undifferentiated osteoblastic MC3T3-E1 cells. In this study, we investigated the expression profile of the xCT subunit of the antiporter as well as the master regulator of osteoblastogenesis runt-related transcription factor-2 (Runx2) in ovariectomized mouse bone. In spinal columns isolated 28 days after ovariectomy, a marked reduction was seen with the intensity of Von Kossa staining used as an index of ossification. In femurs of these ovariectomized mice, a significant decrease was seen in mRNA and protein levels of Runx2 along with increased expression of both mRNA and the corresponding protein for the xCT subunit. To evaluate the possible role of the antiporter in osteoblastogenesis, stable transfectants were established with the xCT subunit toward the culture with osteoblastic differentiation inducers in MC3T3-E1 cells. In stable xCT transfectants cultured under differentiation conditions, marked decreases were seen in nodule formation, Ca(2+) accumulation, and osteoblastic marker gene expression, in addition to downregulation of both mRNA and the corresponding protein for Runx2. Runx2 promoter activity was markedly stimulated in MC3T3-E1 cells transfected with a responsive promoter plasmid after the culture under differentiation conditions, while transient and stable transfection with xCT expression vector invariably prevented the stimulation through an activator protein-1 site. These results suggest that Runx2 expression would be negatively regulated by the cystine/glutamate antiporter expressed by osteoblastic cells at the level of gene transactivation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325781     DOI: 10.1254/jphs.10310fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  5 in total

Review 1.  Wnt signaling and cellular metabolism in osteoblasts.

Authors:  Courtney M Karner; Fanxin Long
Journal:  Cell Mol Life Sci       Date:  2016-11-26       Impact factor: 9.261

2.  The natural polyamines spermidine and spermine prevent bone loss through preferential disruption of osteoclastic activation in ovariectomized mice.

Authors:  Tomomi Yamamoto; Eiichi Hinoi; Hiroyuki Fujita; Takashi Iezaki; Yoshifumi Takahata; Misa Takamori; Yukio Yoneda
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Genome-wide DNA methylation profile analysis in thoracic ossification of the ligamentum flavum.

Authors:  Tianqi Fan; Xiangyu Meng; Chuiguo Sun; Xiaoxi Yang; Guanghui Chen; Weishi Li; Zhongqiang Chen
Journal:  J Cell Mol Med       Date:  2020-06-24       Impact factor: 5.310

4.  Glutamate signaling in healthy and diseased bone.

Authors:  Robert W Cowan; Eric P Seidlitz; Gurmit Singh
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-19       Impact factor: 5.555

5.  Promotion of both proliferation and neuronal differentiation in pluripotent P19 cells with stable overexpression of the glutamine transporter slc38a1.

Authors:  Masato Ogura; Takami Kakuda; Takeshi Takarada; Noritaka Nakamichi; Ryo Fukumori; Yeong-Hun Kim; Eiichi Hinoi; Yukio Yoneda
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.